However, since oncogenic HPVs upregulate ZO-2 expression and forced nuclear accumulation of ZO-2 increases cell proliferation and confers metabolic benefit to cancer cells, we think ZO-2 might be considered as a tumor regulator rather than a tumor suppressor. Here, TJP2 is linked to cancer.